Predicted to enable 2'-5'-oligoadenylate synthetase activity; ATP binding activity; and double-stranded RNA binding activity. Predicted to be involved in several processes, including innate immune response; regulation of cytokine production; and regulation of innate immune response. Predicted to be located in cytoplasm and plasma membrane. Predicted to be active in cytosol; membrane; and nucleoplasm. Orthologous to human OAS3 (2'-5'-oligoadenylate synthetase 3); PARTICIPATES IN hepatitis C pathway; influenza A pathway; measles pathway; INTERACTS WITH 2,2',4,4'-Tetrabromodiphenyl ether; 6-propyl-2-thiouracil; acetamide.
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of OAS3 protein
[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of OAS3 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of OAS3 mRNA
[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of OAS3 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of OAS3 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of OAS3 protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of OAS3 protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of OAS3 protein
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of OAS3 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of OAS3 mRNA